http://ijirss.com/index.php/ijirss/issue/feed International Journal of Innovative Research and Scientific Studies 2026-09-11T00:30:14-05:00 Open Journal Systems <p>International Journal of Innovative Research and Scientific Studies (IJIRSS) is a forum to exchange applied research and knowledge across multiple distinct academic disciplines or fields of study. It caters to interdisciplinary, multidisciplinary, and transdisciplinary research and innovation in emerging fields of scientific studies.</p> <p>Open Access Policy: This journal operates under an Open Access model, providing free and unrestricted access to readers worldwide. Article Processing Charges (APCs) are covered by the authors or their affiliated institutions.</p> <p>Journal Ranking</p> <ul> <li>Scimago: Q3 (<strong>2024</strong>) (Multidisciplinary Category)</li> <li>Impact Score: 1.40</li> <li>IDEAS/RePEc Simple Impact Factor: 0.11</li> </ul> <p>Rapid Publication Timeline: Submitted manuscripts undergo a rigorous peer-review process, with initial editorial decisions communicated to authors within approximately 20 working days of submission. Following acceptance, the publication process is completed within 10 days (based on median values for articles published in 2025).</p> <p>Reviewer Recognition: In recognition of their essential contributions, reviewers who submit timely and comprehensive peer-review reports are awarded discount vouchers. These vouchers can be applied toward the APC of their next submission to the journal.</p> <h3 class="" data-start="98" data-end="121"><strong data-start="102" data-end="121">Indexing Policy</strong></h3> <p class="" data-start="123" data-end="370">Indexing of published articles is solely at the discretion of indexing databases and services. As a publisher (or editor), we do not have any control over the indexing process, including decisions regarding inclusion or the timeline for coverage.</p> <p class="" data-start="372" data-end="623"><strong><em>We cannot guarantee that any specific article will be indexed by a particular database, nor can we influence how or when this may occur. Indexing decisions are made independently by each indexing platform according to their own criteria and schedules.</em></strong></p> <p class="" data-start="625" data-end="789">As such, indexing is not part of our operational responsibilities. We kindly request all authors to understand this distinction and manage expectations accordingly.</p> <p class="" data-start="791" data-end="987"><strong data-start="791" data-end="807">Please note:</strong> <strong><em>The Article Processing Charge (APC) is non-refundable once the article has been published</em></strong>, except in cases where publication is canceled due to an error or decision from our side.</p> http://ijirss.com/index.php/ijirss/article/view/11895 Fitness for service and risk-based inspection for line piping leakage of hydrocarbon release at offshore northwest java topside facility 2026-09-08T09:30:14-05:00 Dona Yuliati Yuliatiadd@gmail.com Donanta Dhaneswara ahyuwono@eng.ui.ac.id Datu Rizal Rizaladd@gmail.com Gusaimas M. H. H. Akbar Akbaradd@gmail.com Akhmad Herman Yuwono Yuwonoadd@gmail.com <p>Hydrocarbon leaks from offshore facilities can pose serious risks to workers, the environment, equipment, and operations. This study evaluated the safety and reliability of a repeatedly leaking three-phase piping system and assessed whether it could continue operating safely over the next 20 years. Fitness-for-Service (FFS) assessment based on API 579-1/ASME FFS-1 and Risk-Based Inspection (RBI) following API 581 were applied to evaluate the piping condition, risk level, remaining service life, and inspection requirements. Field observations and investigations were performed to evaluate piping conditions, while RBI and Estimated Life (EL) calculations were used to assess risk, remaining service life, and future piping conditions. Level 1 and Level 2 FFS assessments indicated that neither piping system could be considered fit for operation over the next 20 years, requiring a more detailed Level 3 assessment. Initially, both piping systems were classified in the yellow risk zone, but the risk was predicted to increase to the orange zone after 72 months. Therefore, The piping systems require further integrity assessment and risk mitigation to support safe long-term operation. Timely inspection, maintenance, repair, or replacement should be implemented to control increasing risk and ensure safe and reliable offshore operations.</p> <p>&nbsp;</p> 2026-09-08T00:00:00-05:00 Copyright (c) 2026 http://ijirss.com/index.php/ijirss/article/view/11900 Mitochondria in Parkinson disease: Genetic and epigenetic components 2026-09-11T00:30:14-05:00 Anastasia V. Poznyak tehhy_85@mail.ru Vsevolod Vyacheslavovich Pavshintsev Pavshintsevadd@gmail.com Aleksandra Sergeevna Utkina Utkinaadd@gmail.com Elizaveta Romanovna Korchagina Korchaginaadd@gmail.com Olga Nikolaevna Maltseva Maltsevaadd@gmail.com Alexander N. Orekhov Orekhovadd@gmail.com <p>This review aims to elucidate the genetic and epigenetic mechanisms underlying mitochondrial dysfunction in Parkinson’s disease (PD) and to explore how these insights inform emerging therapeutic strategies. A comprehensive analysis of current literature was conducted to integrate evidence on mitochondrial homeostasis, mitophagy regulation, and genome stability, with a focus on mutations in&nbsp;<em>SNCA</em>,&nbsp;<em>LRRK2</em>,&nbsp;<em>VPS35</em>,&nbsp;<em>PINK1</em>,&nbsp;<em>PARK2</em>,&nbsp;<em>DJ-1</em>, and&nbsp;<em>POLG</em>, as well as epigenetic alterations affecting mitochondrial DNA. Genetic mutations disrupt mitochondrial dynamics, impair autophagy, and cause oxidative stress, leading to dopaminergic neuron degeneration. Epigenetic modifications—such as altered DNA methylation, histone acetylation, and non-coding RNA regulation—further exacerbate mitochondrial instability and neuronal apoptosis. Mitochondrial impairment represents a common denominator linking hereditary and sporadic forms of PD, providing a unifying model of disease pathogenesis. Advances in understanding mitochondrial biology have enabled the development of novel therapeutic approaches, including activators of the PINK1/Parkin pathway, inhibitors of&nbsp;<em>LRRK2</em>&nbsp;and α-synuclein aggregation, and strategies promoting mitochondrial biogenesis and intercellular transfer, offering potential for disease modification.</p> 2026-09-11T00:00:00-05:00 Copyright (c) 2026